CIK: 1597583 - Address: C/o Revance Therapeutics, Inc., 7555 Gateway Boulevard, Newark, CA 94560
20 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret111684-66113935
P%wins100100100010010083
S%ret115-1-081649014
S%wins60604025037

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/19/19 21:01
3/18/19
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PS-18015.510-12-7152D
2/20/19 21:31
2/19/19
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PS-9617.680-5-3169D
3/16/18 20:03
3/15/18
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PS.dm-20431.640-6-4142D
3/16/18 20:03
3/16/18
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PM.d512.5502016142D
3/9/18 20:36
3/7/18
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PS-85831.430-27-17132D
11/24/17 16:06
11/22/17
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PS-19024.940-8-5134D
10/20/17 20:10
10/18/17
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PS-20026.160-8-5141D
9/22/17 20:08
9/20/17
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PS-17923.580-8-5149D
8/25/17 19:41
8/23/17
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PM.d12.55000156D
8/25/17 19:41
8/23/17
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PS.d-51922.760-23-13156D
6/14/17 20:11
6/12/17
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PM.d212.55085178D
5/31/17 21:38
5/30/17
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PM.d132.55053170D
5/24/17 21:13
5/22/17
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PS.m-64920.290-32-16165D
2/24/17 21:04
2/22/17
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PS-22720.573-11-5200D257288-13-6-4-54-2-3
1/27/17 20:04
1/25/17
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PS-23719.783-12-6185D17-10393218-17-4-3-46617
12/30/16 18:38
12/28/16
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PS-25120.944-12-6196D26-41543211229-3413-30
11/25/16 21:32
11/25/16
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PS-21517.924-12-5208D10-50-530234803-2-52017
10/28/16 21:29
10/26/16
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PS-17814.852-12-5220D-23-44-1911-11-621-9-14203149
1/4/16 21:10
12/30/15
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PM.d312.5512126219D102912-13-6-7-31-15-38-43-58-37
12/1/14 21:26
11/28/14
RVNCRevance Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBrowne L DanielCADOCEO,PP10016.67464174D-45-30-6-172-3684-661139

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact